New! Daffy's Private Stock Donation Program

Daffy

Cure Alzheimer's Fund

Cure Alzheimer's Fund

Wellesley Hills, MA 02481
Tax ID52-2396428

Want to make a donation using Daffy?

Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.

Payment method

Frequency

Amount

$USD
Daffy covers all ACH transaction fees so 100% of your donation goes to your favorite charities.

Do you work for Cure Alzheimer's Fund? Learn more here.

By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.

About this organization

Revenue

$30,582,733

Expenses

$24,308,027

Mission

The mission of Cure Alzheimer's Fund is to fund research with the highest probability of slowing, stopping or reversing Alzheimer's disease.

About

For many years, Alzheimer’s disease research was completely stifled by a lack of funding. Pharmaceutical companies were too wary of past failures to fund any new drug development. The drug pipeline was coming up dry, and researchers weren’t encouraged to think big or bold. Cure Alzheimer’s Fund has changed that. We are a 501(c)(3) nonprofit organization founded in 2004 by three families frustrated by the slow pace of research. Leveraging their experience in venture capital and corporate start-ups, our founders (Jeff Morby, Jacqui Morby, Henry McCance, and Phyllis Rappaport) came together to build a new Alzheimer’s research fund designed to dramatically accelerate research, make bold bets, and focus exclusively on finding a cure. Since its founding, CureAlz has contributed more than $153,000,000 to research, and its funded initiatives have been responsible for several key breakthroughs including a potential treatment recently selected by the National Institutes of Health (NIH) for its elite “Blueprint” drug discovery program, and the ground-breaking “Alzheimer’s in a Dish” study, which promises to greatly accelerate drug testing and was reported by The New York Times as a “giant step forward”. CureAlz supports some of the best scientific minds in the field of Alzheimer’s research and does so without any financial gain for its founders or donors. Fully 100% of donations received by Cure Alzheimer’s Fund go directly to support our research; the Board of Directors pays for our overhead expenses. Our Research Leadership Group is an all-star team of scientists working at premier research institutions across the country, regularly conferring with one another on the progress and impediments in their research and constantly sharing their data. Our goal is to stop Alzheimer’s disease through early prediction, prevention, and effective intervention leading to a cure.

Interesting data from their 2020 990 filing

The purpose of the non-profit, as set forth in the filing, is “To fund research with the highest probability of preventing, slowing or reversing alzheimer's disease through venture based philanthropy with all organizational expenses paid by the board, allowing all public contributions to directly fund alzheimer's research.”.

When discussing its purpose, they were characterized as: “To fund research with the highest probability of preventing, slowing or reversing alzheimer's disease through venture based philanthropy with all organizational expenses paid by the board, allowing all public contributions to directly fund alzheimer's research.”.

  • The state in which the non-profit is legally authorized to operate is PA, as reported.
  • The filing confirms that the non-profit's address in 2020 was 34 WASHINGTON ST NO 310, WELLESLEY HILLS, MA, 02481.
  • The form of the non-profit reports 24 employees as of 2020.
  • Is not a private foundation.
  • Expenses are greater than $1,000,000.
  • Revenue is greater than $1,000,000.
  • Revenue less expenses is $6,274,706.
  • The organization has 8 independent voting members.
  • The organization was formed in 2004.
  • The organization pays $2,117,985 in salary, compensation, and benefits to its employees.
  • The organization pays $1,187,877 in fundraising expenses.